News

Webcast

Webcasts

From Theory to Reality: Automating Process Development

Webinar Date/Time: Fri, Oct 25, 2024 11:00 AM EDT

Developing biomanufacturing processes that rely on automated technologies has grown from theory to reality. In this episode we explore automated technologies in use today and how they are streamlining process development, with an eye toward saving cost, time, and manufacturing footprint.

Register Free: https://www.pharmtech.com/pt_w/theory-to-reality

Event Overview:

In this episode of Drug Digest, industry experts discuss the ongoing advancement of automation in the biopharmaceutical industry. Developing biomanufacturing processes that rely on automated technologies has grown from theory to reality. In this episode we explore automated technologies in use today and how they are streamlining process development, with an eye toward saving cost, time, and manufacturing footprint.
Key Learning Objectives:

  • Facilitating process development
  • Pros/cons of switching to fully automated processes
  • New skills? What should manufacturing personnel know under an automated biomanufacturing system?

Who Should Attend:

  • Process development engineers
  • CDMOs/CMOs
  • Quality Control/Quality Assurance
  • Data analysts

Register Free: https://www.pharmtech.com/pt_w/theory-to-reality


Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content